Mark A Sirgo insider trades: 9 Meters Biopharma (NMTR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
71 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 1, 2022 | NMTR | ↑ Buy | 175,000 | $0.25 | $43K | Direct | Jul 6, 2022 (5d) |
| May 18, 2022 | NMTR | ↑ Buy | 106,383 | $0.47 | $50K | Direct | May 19, 2022 (1d) |
| Mar 3, 2022 | NMTR | ↑ Buy | 86,450 | $0.58 | $50K | Direct | Mar 7, 2022 (4d) |
| Dec 2, 2021 | BDSI | ↑ Buy | 18,587 | $2.69 | $50K | Direct | Dec 6, 2021 (4d) |
| Dec 2, 2021 | NMTR | ↑ Buy | 50,000 | $0.89 | $45K | Direct | Dec 3, 2021 (1d) |
| Nov 18, 2021 | NMTR | ↑ Buy | 20,000 | $1.06 | $21K | Direct | Nov 22, 2021 (4d) |
| Nov 18, 2021 | BDSI | ↓ Sell | 10,000 | $3.04 | $30K | Direct | Nov 19, 2021 (1d) |
| Nov 11, 2021 | BDSI | ↑ Buy | 16,000 | $3.20 | $51K | Direct | Nov 12, 2021 (1d) |
| Sep 7, 2021 | NMTR | ↑ Buy | 73,529 | $1.36 | $100K | Direct | Sep 8, 2021 (1d) |
| Aug 20, 2021 | NMTR | ↑ Buy | 25,000 | $1.10 | $28K | Direct | Aug 23, 2021 (3d) |
| May 13, 2021 | BDSI | ↑ Buy | 15,500 | $3.19 | $49K | Direct | May 13, 2021 (0d) |
| Apr 5, 2021 | NMTR | ↑ Buy | 300,000 | $1.00 | $300K | Direct | Apr 6, 2021 (1d) |
| Dec 15, 2020 | NMTR | ↑ Buy | 230,769 | $0.65 | $150K | Direct | Dec 17, 2020 (2d) |
| Sep 11, 2020 | NMTR | ↑ Buy | 127,000 | $0.65 | $82K | Direct | Sep 14, 2020 (3d) |
| Sep 11, 2020 | NMTR | ↑ Buy | 21,485 | $0.65 | $14K | by spouse | Sep 14, 2020 (3d) |
| Aug 17, 2020 | NMTR | ↑ Buy | 100,000 | $0.56 | $56K | Direct | Aug 18, 2020 (1d) |
| Aug 14, 2020 | BDSI | ↓ Sell | 200,000 | $4.74 | $949K | Direct | Aug 17, 2020 (3d) |
| Jun 15, 2020 | NMTR | ↑ Buy | 17,943 | $0.60 | $11K | Direct | Jun 16, 2020 (1d) |
| May 8, 2020 | BDSI | ↓ Sell | 100,000 | $5.07 | $507K | Direct | May 12, 2020 (4d) |
| Apr 27, 2020 | BDSI | ↓ Sell | 100,000 | $4.58 | $458K | Direct | Apr 29, 2020 (2d) |
| Apr 21, 2020 | BMRA | ↓ Sell | 10,000 | $8.09 | $81K | Direct | Apr 21, 2020 (0d) |
| Apr 15, 2020 | BDSI | ↓ Sell | 50,000 | $4.13 | $207K | Direct | Apr 17, 2020 (2d) |
| Jan 7, 2020 | BDSI | ↓ Sell | 13,353 | $5.65 | $75K | Direct | Jan 9, 2020 (2d) |
| Jan 6, 2020 | BDSI | ↓ Sell | 86,647 | $6.02 | $522K | Direct | Jan 6, 2020 (0d) |
| Oct 18, 2019 | BDSI | ↓ Sell | 84,228 | $5.15 | $434K | Direct | Oct 22, 2019 (4d) |
| Oct 17, 2019 | BDSI | ↓ Sell | 144,093 | $5.03 | $725K | Direct | Oct 17, 2019 (0d) |
| Sep 19, 2019 | BDSI | ↓ Sell | 225,369 | $4.79 | $1.1M | Direct | Sep 19, 2019 (0d) |
| Jun 25, 2019 | BDSI | ↓ Sell | 90,706 | $4.39 | $398K | Direct | Jun 27, 2019 (2d) |
| Jun 12, 2019 | BDSI | ↓ Sell | 484,752 | $4.22 | $2.0M | Direct | Jun 13, 2019 (1d) |
| Mar 21, 2019 | BDSI | ↓ Sell | 9,050 | $5.20 | $47K | Direct | Mar 22, 2019 (1d) |
| Jan 2, 2019 | BDSI | ↓ Sell | 9,175 | $3.57 | $33K | Direct | Jan 4, 2019 (2d) |
| Dec 27, 2018 | BDSI | ↓ Sell | 10,000 | $2.91 | $29K | Direct | Dec 28, 2018 (1d) |
| Apr 10, 2018 | BDSI | ↓ Sell | 100,000 | $2.06 | $206K | Direct | Apr 13, 2018 (3d) |
| Jan 19, 2018 | BDSI | ↓ Sell10b5-1 | 709,502 | $2.73 | $1.9M | Direct | Jan 19, 2018 (0d) |
| Sep 21, 2017 | BDSI | ↓ Sell | 201,373 | $2.84 | $573K | Direct | Sep 22, 2017 (1d) |
| Mar 31, 2017 | BDSI | ↓ Sell | 110,895 | $1.90 | $211K | Direct | Mar 31, 2017 (0d) |
| Aug 3, 2016 | BMRA | ↑ Buy | 4,000 | $2.05 | $8K | Direct | Aug 3, 2016 (0d) |
| Aug 2, 2016 | BMRA | ↑ Buy | 8,000 | $1.97 | $16K | Direct | Aug 3, 2016 (1d) |
| Jun 16, 2015 | BDSI | ↓ Sell | 4,187 | $7.97 | $33K | Direct | Jun 17, 2015 (1d) |
| Feb 25, 2015 | BDSI | ↓ Sell | 94,000 | $14.25 | $1.3M | Direct | Feb 27, 2015 (2d) |
| Dec 15, 2014 | BDSI | ↑ Buy | 2,500 | $12.23 | $31K | Direct | Dec 16, 2014 (1d) |
| Sep 4, 2014 | BDSI | ↑ Buy | 480 | $15.90 | $8K | By Spouse | Sep 8, 2014 (4d) |
| Sep 4, 2014 | BDSI | ↑ Buy | 2,000 | $15.04 | $30K | Direct | Sep 5, 2014 (1d) |
| Feb 20, 2014 | BDSI | ↓ Sell | 42,000 | $8.92 | $375K | Direct | Feb 21, 2014 (1d) |
| Jan 24, 2014 | BDSI | ↓ Sell | 116,253 | $9.01 | $1.0M | Direct | Jan 28, 2014 (4d) |
| Nov 18, 2013 | BDSI | ↑ Buy | 2,337 | $4.29 | $10K | Direct | Nov 19, 2013 (1d) |
| Aug 16, 2013 | BDSI | ↑ Buy | 5,100 | $4.43 | $23K | Direct | Aug 19, 2013 (3d) |
| Jun 21, 2013 | BDSI | ↑ Buy | 3,400 | $4.30 | $15K | Direct | Jun 24, 2013 (3d) |
| May 3, 2013 | SLXP | ↓ Sell | 2,008 | $54.00 | $108K | Direct | May 7, 2013 (4d) |
| Mar 20, 2013 | SLXP | ↓ Sell | 3,000 | $50.05 | $150K | Direct | Mar 22, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark A Sirgo's insider trades
Mark A Sirgo is a director at 9 Meters Biopharma (NMTR). Since Sep 30, 2005, Mark has reported 39 open-market purchases worth $1.4M and 32 sales worth $14.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (14% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (47 filings), option exercises (16 filings), other transactions (7 filings), shares withheld for taxes (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NMTR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.